Moira C Graves

4PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 16, 2023
Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade-resistant Melanoma for Anti-PD-L1 Rechallenge.

Andre van der Westhuizen, Megan Lyle, Moira C Graves

|Jun 15, 2021
Overall survival in metastatic melanoma correlates with pembrolizumab exposure and T cell exhaustion markers.

Vishal Navani, Moira C Graves, Giovana Celli Marchett

|May 31, 2021
DNA damage repair in glioblastoma: current perspectives on its role in tumour progression, treatment resistance and PIKKing potential therapeutic targets.

Mathew Lozinski, Nikola A Bowden, Moira C Graves

|May 09, 2020
Immune checkpoint blockade in solid organ tumours: Choice, dose and predictors of response.

Vishal Navani, Moira C Graves, Nikola A Bowden

Pageof 1